Recent Developments of Structure Based &bgr;-Secretase Inhibitors for Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 16, 2005-12 ,pp. : 1609-1622

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of &bgr;-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer’s Disease- Epilepsy Linkage via an Enzoinformatics Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1258-1262

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Anti-Amyloid Therapy for Alzheimer’s Disease: From Secretase Modulators to Polymerisation Inhibitors

By Aisen Paul S.  

CNS Drugs, Vol. 19, Iss. 12, 2005-01 ,pp. : 989-996

Adis International

Access to resources Recommend Favorite

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite